Gary S. Gillheeney's most recent trade in Organogenesis Holdings Inc - Ordinary Shares - Class A was a trade of 732,596 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Feb. 19, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Organogenesis Holdings Inc... | Gary S. Gillheeney | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Feb 2025 | 732,596 | 732,596 | - | - | Stock Option (Right to Buy) | |
| Organogenesis Holdings Inc... | Gary S. Gillheeney | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Feb 2025 | 708,215 | 3,515,323 (3%) | 0% | 0 | Class A Common Stock | |
| Organogenesis Holdings Inc... | Gary S. Gillheeney | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.70 per share. | 15 Feb 2025 | 109,280 | 2,847,100 (2%) | 0% | 3.7 | 404,336 | Class A Common Stock |
| Organogenesis Holdings Inc... | Gary S. Gillheeney | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.70 per share. | 15 Feb 2025 | 82,814 | 2,956,380 (2%) | 0% | 3.7 | 306,412 | Class A Common Stock |
| Organogenesis Holdings Inc... | Gary S. Gillheeney | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.70 per share. | 15 Feb 2025 | 33,869 | 2,813,231 (2%) | 0% | 3.7 | 125,315 | Class A Common Stock |
| Organogenesis Holdings Inc... | Gary S. Gillheeney | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.70 per share. | 15 Feb 2025 | 6,123 | 2,807,108 (2%) | 0% | 3.7 | 22,655 | Class A Common Stock |
| Organogenesis Holdings Inc... | Gary S. Gillheeney | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 3.36 per share. | 13 Dec 2024 | 55,615 | 3,044,779 (2%) | 0% | 3.4 | 186,866 | Class A Common Stock |
| Organogenesis Holdings Inc... | Gary S. Gillheeney | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 3.49 per share. | 13 Dec 2024 | 5,585 | 3,039,194 (2%) | 0% | 3.5 | 19,492 | Class A Common Stock |
| Organogenesis Holdings Inc... | Gary S. Gillheeney | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 3.64 per share. | 10 Dec 2024 | 157,448 | 3,143,753 (3%) | 0% | 3.6 | 573,111 | Class A Common Stock |
| Organogenesis Holdings Inc... | Gary S. Gillheeney | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 3.64 per share. | 10 Dec 2024 | 58,525 | 3,301,201 (3%) | 0% | 3.6 | 213,031 | Class A Common Stock |
| Organogenesis Holdings Inc... | Gary S. Gillheeney | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 3.55 per share. | 10 Dec 2024 | 43,359 | 3,100,394 (2%) | 0% | 3.5 | 153,924 | Class A Common Stock |
| Organogenesis Holdings Inc... | Gary S. Gillheeney | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.99 per share. | 05 Dec 2024 | 1,067,245 | 3,419,194 (3%) | 1% | 1.0 | 1,056,573 | Class A Common Stock |
| Organogenesis Holdings Inc... | Gary S. Gillheeney | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Dec 2024 | 1,067,245 | 0 | - | - | Stock Option (Right to Buy) | |
| Organogenesis Holdings Inc... | Gary S. Gillheeney | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 3.52 per share. | 05 Dec 2024 | 41,052 | 3,359,726 (3%) | 0% | 3.5 | 144,503 | Class A Common Stock |
| Organogenesis Holdings Inc... | Gary S. Gillheeney | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 3.65 per share. | 05 Dec 2024 | 18,416 | 3,400,778 (3%) | 0% | 3.6 | 67,218 | Class A Common Stock |
| Organogenesis Holdings Inc... | Gary S. Gillheeney | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.80 per share. | 01 Apr 2024 | 10,113 | 2,351,949 (2%) | 0% | 2.8 | 28,316 | Class A Common Stock |
| Organogenesis Holdings Inc... | Gary S. Gillheeney | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Feb 2024 | 1,238,729 | 1,238,729 | - | - | Stock Option (Right to Buy) | |
| Organogenesis Holdings Inc... | Gillheeney S. Gary | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Feb 2024 | 685,131 | 2,362,062 (2%) | 0% | 0 | Class A Common Stock | |
| Organogenesis Holdings Inc... | S. Gary Gillheeney | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.68 per share. | 15 Feb 2024 | 65,774 | 1,702,158 (1%) | 0% | 3.7 | 242,048 | Class A Common Stock |
| Organogenesis Holdings Inc... | Gary S. Gillheeney | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.68 per share. | 15 Feb 2024 | 21,439 | 1,680,719 (1%) | 0% | 3.7 | 78,896 | Class A Common Stock |
| Organogenesis Holdings Inc... | S. Gary Gillheeney | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.48 per share. | 15 Feb 2024 | 3,788 | 1,676,931 (1%) | 0% | 3.5 | 13,182 | Class A Common Stock |
| Organogenesis Holdings Inc... | Gary S. Gillheeney | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.13 per share. | 01 Apr 2023 | 6,470 | 1,767,932 (1%) | 0% | 2.1 | 13,781 | Class A Common Stock |
| Organogenesis Holdings Inc... | Gary S. Gillheeney | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Feb 2023 | 1,655,381 | 1,655,381 | - | - | Stock Option (Right to Buy) | |
| Organogenesis Holdings Inc... | Gary S. Gillheeney | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Feb 2023 | 896,414 | 1,774,402 (1%) | 0% | 0 | Class A Common Stock | |
| Organogenesis Holdings Inc... | Gary S. Gillheeney | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.92 per share. | 15 Feb 2023 | 21,517 | 881,775 (0%) | 0% | 2.9 | 62,830 | Class A Common Stock |
| Organogenesis Holdings Inc... | Gary S. Gillheeney | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.75 per share. | 15 Feb 2023 | 3,787 | 877,988 (0%) | 0% | 2.7 | 10,414 | Class A Common Stock |
| Organogenesis Holdings Inc... | Gary S. Gillheeney | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.99 per share. | 30 Jun 2022 | 505,050 | 903,292 (0%) | 0% | 1.0 | 500,000 | Class A Common Stock |
| Organogenesis Holdings Inc... | Gary S. Gillheeney | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Jun 2022 | 505,050 | 0 | - | - | Stock Option (Right to Buy) | |
| Organogenesis Holdings Inc... | Gary S. Gillheeney | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jun 2022 | 116,608 | 36,239 | - | - | Stock Option (Right to Buy) | |
| Organogenesis Holdings Inc... | Gary S. Gillheeney | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 5.58 per share. | 01 Jun 2022 | 116,608 | 398,242 (0%) | 0% | 5.6 | 650,673 | Class A Common Stock |
| Organogenesis Holdings Inc... | Gary S. Gillheeney | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.99 per share. | 01 Jun 2022 | 116,608 | 514,850 (0%) | 0% | 1.0 | 115,442 | Class A Common Stock |
| Organogenesis Holdings Inc... | Gary S. Gillheeney | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jun 2022 | 94,487 | 152,847 | - | - | Stock Option (Right to Buy) | |
| Organogenesis Holdings Inc... | Gary S. Gillheeney | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 5.52 per share. | 01 Jun 2022 | 94,487 | 398,242 (0%) | 0% | 5.5 | 521,568 | Class A Common Stock |
| Organogenesis Holdings Inc... | Gary S. Gillheeney | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.99 per share. | 01 Jun 2022 | 94,487 | 492,729 (0%) | 0% | 1.0 | 93,542 | Class A Common Stock |
| Organogenesis Holdings Inc... | Gary S. Gillheeney | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jun 2022 | 36,239 | 0 | - | - | Stock Option (Right to Buy) | |
| Organogenesis Holdings Inc... | Gary S. Gillheeney | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 5.53 per share. | 01 Jun 2022 | 36,239 | 398,242 (0%) | 0% | 5.5 | 200,402 | Class A Common Stock |
| Organogenesis Holdings Inc... | Gary S. Gillheeney | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.99 per share. | 01 Jun 2022 | 36,239 | 434,481 (0%) | 0% | 1.0 | 35,877 | Class A Common Stock |
| Organogenesis Holdings Inc... | Gary S. Gillheeney | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 5.68 per share. | 26 May 2022 | 109,240 | 398,242 (0%) | 0% | 5.7 | 620,483 | Class A Common Stock |
| Organogenesis Holdings Inc... | Gary S. Gillheeney | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.99 per share. | 26 May 2022 | 109,240 | 507,482 (0%) | 0% | 1.0 | 108,148 | Class A Common Stock |
| Organogenesis Holdings Inc... | Gary S. Gillheeney | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 May 2022 | 109,240 | 247,334 | - | - | Stock Option (Right to Buy) | |
| Organogenesis Holdings Inc... | Gary S. Gillheeney | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 May 2022 | 61,202 | 412,936 | - | - | Stock Option (Right to Buy) | |
| Organogenesis Holdings Inc... | Gary S. Gillheeney | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 5.71 per share. | 26 May 2022 | 61,202 | 398,242 (0%) | 0% | 5.7 | 349,463 | Class A Common Stock |
| Organogenesis Holdings Inc... | Gary S. Gillheeney | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.99 per share. | 26 May 2022 | 61,202 | 459,444 (0%) | 0% | 1.0 | 60,590 | Class A Common Stock |
| Organogenesis Holdings Inc... | Gary S. Gillheeney | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 5.93 per share. | 26 May 2022 | 56,362 | 398,242 (0%) | 0% | 5.9 | 334,227 | Class A Common Stock |
| Organogenesis Holdings Inc... | Gary S. Gillheeney | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.99 per share. | 26 May 2022 | 56,362 | 454,604 (0%) | 0% | 1.0 | 55,798 | Class A Common Stock |
| Organogenesis Holdings Inc... | Gary S. Gillheeney | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 May 2022 | 56,362 | 356,574 | - | - | Stock Option (Right to Buy) | |
| Organogenesis Holdings Inc... | Gary S. Gillheeney | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 May 2022 | 84,674 | 474,138 | - | - | Stock Option (Right to Buy) | |
| Organogenesis Holdings Inc... | Gary S. Gillheeney | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 5.60 per share. | 23 May 2022 | 84,674 | 398,242 (0%) | 0% | 5.6 | 474,174 | Class A Common Stock |
| Organogenesis Holdings Inc... | Gary S. Gillheeney | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.99 per share. | 23 May 2022 | 84,674 | 482,916 (0%) | 0% | 1.0 | 83,827 | Class A Common Stock |
| Organogenesis Holdings Inc... | Gary S. Gillheeney | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.99 per share. | 23 May 2022 | 53,680 | 458,592 (0%) | 0% | 1.0 | 53,143 | Class A Common Stock |
| Organogenesis Holdings Inc... | Gary S. Gillheeney | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 May 2022 | 53,680 | 611,124 | - | - | Stock Option (Right to Buy) | |
| Organogenesis Holdings Inc... | Gary S. Gillheeney | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 5.80 per share. | 23 May 2022 | 53,680 | 398,242 (0%) | 0% | 5.8 | 311,344 | Class A Common Stock |
| Organogenesis Holdings Inc... | Gary S. Gillheeney | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 5.66 per share. | 23 May 2022 | 52,312 | 398,242 (0%) | 0% | 5.7 | 296,086 | Class A Common Stock |
| Organogenesis Holdings Inc... | Gary S. Gillheeney | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 May 2022 | 52,312 | 558,812 | - | - | Stock Option (Right to Buy) | |
| Organogenesis Holdings Inc... | Gary S. Gillheeney | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.99 per share. | 23 May 2022 | 52,312 | 450,554 (0%) | 0% | 1.0 | 51,789 | Class A Common Stock |
| Organogenesis Holdings Inc... | Gary S. Gillheeney | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 5.84 per share. | 23 May 2022 | 6,670 | 451,922 (0%) | 0% | 5.8 | 38,953 | Class A Common Stock |
| Organogenesis Holdings Inc... | Gary S. Gillheeney | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.99 per share. | 23 May 2022 | 6,670 | 404,912 (0%) | 0% | 1.0 | 6,603 | Class A Common Stock |
| Organogenesis Holdings Inc... | Gary S. Gillheeney | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 May 2022 | 6,670 | 1,067,245 | - | - | Stock Option (Right to Buy) | |
| Organogenesis Holdings Inc... | Gary S. Gillheeney | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 May 2022 | 118,504 | 1,132,569 | - | - | Stock Option (Right to Buy) | |
| Organogenesis Holdings Inc... | Gary S. Gillheeney | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.99 per share. | 18 May 2022 | 118,504 | 516,746 (0%) | 0% | 1.0 | 117,319 | Class A Common Stock |
| Organogenesis Holdings Inc... | Gary S. Gillheeney | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 5.94 per share. | 18 May 2022 | 118,504 | 398,242 (0%) | 0% | 5.9 | 703,914 | Class A Common Stock |
| Organogenesis Holdings Inc... | Gary S. Gillheeney | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.99 per share. | 18 May 2022 | 86,531 | 484,773 (0%) | 0% | 1.0 | 85,666 | Class A Common Stock |
| Organogenesis Holdings Inc... | Gary S. Gillheeney | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 5.46 per share. | 18 May 2022 | 86,531 | 398,242 (0%) | 0% | 5.5 | 472,459 | Class A Common Stock |
| Organogenesis Holdings Inc... | Gary S. Gillheeney | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 May 2022 | 86,531 | 1,251,073 | - | - | Stock Option (Right to Buy) | |
| Organogenesis Holdings Inc... | Gary S. Gillheeney | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.99 per share. | 18 May 2022 | 58,654 | 456,896 (0%) | 0% | 1.0 | 58,067 | Class A Common Stock |
| Organogenesis Holdings Inc... | Gary S. Gillheeney | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 5.89 per share. | 18 May 2022 | 58,654 | 398,242 (0%) | 0% | 5.9 | 345,472 | Class A Common Stock |
| Organogenesis Holdings Inc... | Gary S. Gillheeney | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 May 2022 | 58,654 | 1,073,915 | - | - | Stock Option (Right to Buy) | |
| Organogenesis Holdings Inc... | Gary S. Gillheeney | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 May 2022 | 121,580 | 1,516,051 | - | - | Stock Option (Right to Buy) | |
| Organogenesis Holdings Inc... | Gary S. Gillheeney | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 6.18 per share. | 13 May 2022 | 121,580 | 398,242 (0%) | 0% | 6.2 | 751,364 | Class A Common Stock |
| Organogenesis Holdings Inc... | Gary S. Gillheeney | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.99 per share. | 13 May 2022 | 121,580 | 534,632 (0%) | 0% | 1.0 | 120,364 | Class A Common Stock |
| Organogenesis Holdings Inc... | Gary S. Gillheeney | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 May 2022 | 98,078 | 1,337,604 | - | - | Stock Option (Right to Buy) | |
| Organogenesis Holdings Inc... | Gary S. Gillheeney | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 5.90 per share. | 13 May 2022 | 98,078 | 398,242 (0%) | 0% | 5.9 | 578,660 | Class A Common Stock |
| Organogenesis Holdings Inc... | Gary S. Gillheeney | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.99 per share. | 13 May 2022 | 98,078 | 496,320 (0%) | 0% | 1.0 | 97,097 | Class A Common Stock |
| Organogenesis Holdings Inc... | Gary S. Gillheeney | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 May 2022 | 80,369 | 1,435,682 | - | - | Stock Option (Right to Buy) | |
| Organogenesis Holdings Inc... | Gary S. Gillheeney | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 5.92 per share. | 13 May 2022 | 80,369 | 398,242 (0%) | 0% | 5.9 | 475,784 | Class A Common Stock |
| Organogenesis Holdings Inc... | Gary S. Gillheeney | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.99 per share. | 13 May 2022 | 80,369 | 478,611 (0%) | 0% | 1.0 | 79,565 | Class A Common Stock |
| Organogenesis Holdings Inc... | Gary S. Gillheeney | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.99 per share. | 13 May 2022 | 14,810 | 413,052 (0%) | 0% | 1.0 | 14,662 | Class A Common Stock |
| Organogenesis Holdings Inc... | Gary S. Gillheeney | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 May 2022 | 14,810 | 505,050 | - | - | Stock Option (Right to Buy) | |
| Organogenesis Holdings Inc... | Gary S. Gillheeney | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 6.06 per share. | 13 May 2022 | 14,810 | 519,822 (0%) | 0% | 6.1 | 89,749 | Class A Common Stock |
| Organogenesis Holdings Inc... | Gary S. Gillheeney | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.89 per share. | 01 Apr 2022 | 9,789 | 398,242 (0%) | 0% | 7.9 | 77,235 | Class A Common Stock |
| Organogenesis Holdings Inc... | Gary S. Gillheeney | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2022 | 664,532 | 664,532 | - | - | Stock Option (Right to Buy) | |
| Organogenesis Holdings Inc... | Gary S. Gillheeney | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2022 | 280,199 | 412,116 (0%) | 0% | 0 | Class A Common Stock | |
| Organogenesis Holdings Inc... | Gary S. Gillheeney | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.78 per share. | 15 Feb 2022 | 4,085 | 408,031 (0%) | 0% | 7.8 | 31,781 | Class A Common Stock |
| Organogenesis Holdings Inc... | Gary S. Gillheeney | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 14.02 per share. | 16 Jul 2021 | 160,237 | 131,917 (0%) | 0% | 14.0 | 2,246,523 | Class A Common Stock |
| Organogenesis Holdings Inc... | Gary S. Gillheeney | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.99 per share. | 16 Jul 2021 | 160,237 | 292,154 (0%) | 0% | 1.0 | 158,635 | Class A Common Stock |
| Organogenesis Holdings Inc... | Gary S. Gillheeney | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Jul 2021 | 160,237 | 519,860 | - | - | Stock Option (Right to Buy) | |
| Organogenesis Holdings Inc... | Gary S. Gillheeney | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.04 per share. | 16 Jul 2021 | 115,450 | 271,680 (0%) | 0% | 4.0 | 466,418 | Class A Common Stock |
| Organogenesis Holdings Inc... | Gary S. Gillheeney | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Jul 2021 | 115,450 | 465,392 | - | - | Stock Option (Right to Buy) | |
| Organogenesis Holdings Inc... | Gary S. Gillheeney | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 14.58 per share. | 16 Jul 2021 | 110,329 | 161,351 (0%) | 0% | 14.6 | 1,608,597 | Class A Common Stock |
| Organogenesis Holdings Inc... | Gary S. Gillheeney | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 15.33 per share. | 16 Jul 2021 | 29,434 | 131,917 (0%) | 0% | 15.3 | 451,223 | Class A Common Stock |
| Organogenesis Holdings Inc... | Gary S. Gillheeney | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.99 per share. | 16 Jul 2021 | 24,313 | 156,230 (0%) | 0% | 1.0 | 24,070 | Class A Common Stock |
| Organogenesis Holdings Inc... | Gary S. Gillheeney | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Jul 2021 | 24,313 | 680,097 | - | - | Stock Option (Right to Buy) | |
| Organogenesis Holdings Inc... | Gary S. Gillheeney | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 19.83 per share. | 01 Apr 2021 | 7,890 | 131,917 (0%) | 0% | 19.8 | 156,459 | Class A Common Stock |
| Organogenesis Holdings Inc... | Gary S. Gillheeney | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2021 | 395,289 | 395,289 | - | - | Stock Option (Right to Buy) | |
| Organogenesis Holdings Inc... | Gary S. Gillheeney | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 13.30 per share. | 16 Feb 2021 | 78,201 | 167,644 (0%) | 0% | 13.3 | 1,040,073 | Class A Common Stock |
| Organogenesis Holdings Inc... | Gary S. Gillheeney | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2021 | 51,626 | 245,845 (0%) | 0% | 0 | Class A Common Stock | |
| Organogenesis Holdings Inc... | Gary S. Gillheeney | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 12.85 per share. | 16 Feb 2021 | 16,663 | 139,807 (0%) | 0% | 12.9 | 214,120 | Class A Common Stock |
| Organogenesis Holdings Inc... | Gary S. Gillheeney | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 13.82 per share. | 16 Feb 2021 | 11,174 | 156,470 (0%) | 0% | 13.8 | 154,425 | Class A Common Stock |
| Organogenesis Holdings Inc... | Gary S. Gillheeney | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 13.12 per share. | 11 Feb 2021 | 111,406 | 194,219 (0%) | 0% | 13.1 | 1,461,647 | Class A Common Stock |
| Organogenesis Holdings Inc... | Gary S. Gillheeney | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 12.96 per share. | 11 Feb 2021 | 77,938 | 339,016 (0%) | 0% | 13.0 | 1,010,076 | Class A Common Stock |
| Organogenesis Holdings Inc... | Gary S. Gillheeney | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 13.82 per share. | 11 Feb 2021 | 69,127 | 416,954 (0%) | 0% | 13.8 | 955,335 | Class A Common Stock |